Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.

Kuramoto T, Senzaki H, Koike H, Yamagiwa K, Tamura S, Fujimoto T, Inagaki T.

Case Rep Urol. 2013;2013:303727. doi: 10.1155/2013/303727. Epub 2013 Sep 29.

2.

Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.

Karakolios A, Kasapis C, Kallinikidis T, Kalpidis P, Grigoriadis N.

Clin Gastroenterol Hepatol. 2003 Nov;1(6):480-3.

PMID:
15017648
3.

Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma.

Dourakis SP, Sinani C, Deutsch M, Dimitriadou E, Hadziyannis SJ.

Eur J Gastroenterol Hepatol. 1997 Mar;9(3):311-4.

PMID:
9096437
4.

Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Okano A, Ohana M, Kusumi F.

Clin J Gastroenterol. 2014 Jun;7(3):278-82. doi: 10.1007/s12328-014-0484-4. Epub 2014 Apr 12.

PMID:
26183750
5.

Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report.

Tomadoni A, García C, Márquez M, Ayala JC, Prado F.

Arch Esp Urol. 2010 Mar;63(2):154-6.

PMID:
20378939
6.

Paraneoplastic cholestasis associated with prostate carcinoma.

Koruk M, Büyükberber M, Savaş C, Kadayifçi A.

Turk J Gastroenterol. 2004 Mar;15(1):53-5.

7.

Stauffer's syndrome variant with cholestatic jaundice: a case report.

Morla D, Alazemi S, Lichtstein D.

J Gen Intern Med. 2006 Jul;21(7):C11-3.

8.

Stauffer's syndrome variant associated with renal cell carcinoma.

Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C.

Int J Urol. 2005 Aug;12(8):757-9.

9.

Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.

Chou JW, Yu CJ, Chuang PH, Lai HC, Hsu CH, Cheng KS, Peng CY, Chiang IP.

Ann Pharmacother. 2008 Dec;42(12):1887-92. doi: 10.1345/aph.1L229. Epub 2008 Nov 18.

PMID:
19017832
10.

Atypical presentation of an advanced obstructive biliary cancer without jaundice.

Salvador VB, Samrao P, Leytin A, Basith M.

Am J Case Rep. 2013 Nov 6;14:462-6. doi: 10.12659/AJCR.889620. eCollection 2013.

11.

Hydralazine-induced cholestatic hepatitis.

Hassan A, Hammad R, Cucco R, Niranjan S.

Am J Ther. 2009 Jul-Aug;16(4):371-3. doi: 10.1097/MJT.0b013e31817fde85.

PMID:
19092641
12.

Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.

Leeuwenburgh I, Lugtenburg EP, van Buuren HR, Zondervan PE, de Man RA.

Eur J Gastroenterol Hepatol. 2008 Feb;20(2):145-7. doi: 10.1097/MEG.0b013e3282b9e6c2.

PMID:
18188038
13.

Clinical vignette in antiretroviral therapy: jaundice.

Zell SC.

J Int Assoc Physicians AIDS Care (Chic). 2003 Oct-Dec;2(4):133-9.

PMID:
14986514
14.

Hepatic tuberculosis presenting as cholestatic jaundice. A case report.

Ghoda MK.

Trop Gastroenterol. 2005 Oct-Dec;26(4):203-4.

PMID:
16737053
15.

Obstructive jaundice as a presenting symptom of metastatic carcinoma of the prostate.

Sahai A, Lai CW, Constantinescu G, Hammadeh MY.

BMJ Case Rep. 2009;2009. pii: bcr05.2009.1839. doi: 10.1136/bcr.05.2009.1839. Epub 2009 Aug 20.

16.

Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.

Kato D, Okwara C, Moreland C, Parker A.

J Investig Med High Impact Case Rep. 2014 Jun 24;2(2):2324709614539927. doi: 10.1177/2324709614539927. eCollection 2014 Apr-Jun.

17.

Paraneoplastic jaundice and prostate cancer.

Vieira AC, Alvarenga MJ, Santos JC, Silva AM.

BMJ Case Rep. 2017 Apr 22;2017. pii: bcr-2016-218001. doi: 10.1136/bcr-2016-218001.

PMID:
28433972
18.

Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Qin LX, Tang ZY.

World J Gastroenterol. 2003 Mar;9(3):385-91. Review.

19.

Biliary tract injuries during laparoscopic cholecystectomy: three case reports and literature review.

Parmeggiani D, Cimmino G, Cerbone D, Avenia N, Ruggero R, Gubitosi A, Docimo G, Mordente S, Misso C, Parmeggiani U.

G Chir. 2010 Jan-Feb;31(1-2):16-9. Review.

PMID:
20298660
20.

An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report.

Patel KJ, Latif SU, de Calaca WM.

J Hematol Oncol. 2009 Mar 12;2:12. doi: 10.1186/1756-8722-2-12.

Supplemental Content

Support Center